FDA
approval
· 2009-04-29
FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Supplemental Application (BluePoint Laboratories)
Summary
FDA approved a supplemental application for Triamterene and Hydrochlorothiazide submitted by BluePoint Laboratories. The product is a generic diuretic combinati…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TRIAMTERENE AND HYDROCHLOROTHIAZIDE (TRIAMTERENE AND HYDROCHLOROTHIAZIDE)